Research Interest in Retatrutide Retatrutide is widely discussed in scientific research because of its activity across three receptor pathways: GLP-1, GIP and glucagon
Individuals on retatrutide, particularly for weight management, need to be aware of potential side effects, how to identify them, and when to reach out to their healthcare teams
These are clinical observations, not controlled trial data
You should not take semaglutide if you have 3 Personal or family history of medullary thyroid carcinoma (MTC) or other active thyroid cancer Multiple endocrine neoplasia syndrome type 2 (MEN 2) Known allergy to semaglutide or its components Compounded semaglutide is contraindicated for individuals with certain conditions, including kidney disease, an unknown cause of pancreatitis, active gallbladder disease, diabetic ketoacidosis, type 1 diabetes, pregnancy or plans to become pregnant, suicidal ideation, or diabetic retinopathy